| |
| |
|
| Insider
Information: |
Brzeczko Albert W |
| Relationship: |
See Remarks |
| City: |
Palatine |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
486,001 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,993 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
486,001 |
|
|
| Total
Value |
$1,993 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acura Pharmaceuticals Inc |
ACUR |
See Remarks |
2023-11-20 |
486,001 |
2009-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACUR |
Acura Pharmaceuticals Inc |
See Remarks |
• – – |
2023-11-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
486,001 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
See Remark |
• – – |
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,000 |
446,001 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP, Pharma Sciences - APT |
• – – |
2022-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
43,333 |
412,001 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP, Pharmaceutical Sciences |
• – – |
2021-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
43,334 |
368,668 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Pharmaceutical Sciences APT |
• – – |
2020-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,334 |
325,334 |
0 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Technical Affairs - APT |
• – – |
2017-12-14 |
4 |
B |
$0.10 |
$30,000 |
D/D |
300,000 |
316,000 |
2.74 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Technical Affairs - APT |
• – – |
2017-08-29 |
4 |
B |
$0.47 |
$1,880 |
D/D |
4,000 |
16,000 |
2.66 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Technical Affairs - APT |
• – – |
2017-08-28 |
4 |
B |
$0.45 |
$909 |
D/D |
2,000 |
12,000 |
2.66 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Technical Affairs - APT |
• – – |
2017-08-25 |
4 |
B |
$0.48 |
$2,304 |
D/D |
4,800 |
10,000 |
2.66 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Technical Affairs - APT |
• – – |
2014-05-19 |
4 |
B |
$1.20 |
$2,400 |
D/D |
2,000 |
26,000 |
2.66 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Technical Affairs - APT |
• – – |
2013-11-25 |
4 |
B |
$1.70 |
$2,066 |
D/D |
1,215 |
24,000 |
2.66 |
- |
|
| ACUR |
Acura Pharmaceuticals Inc |
VP Technical Affairs |
• – – |
2009-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
24,000 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
